Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, Egypt: Retrospective analysis.

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 2, Issue 3, 2010, Pages

  Tonbary, Youssef Al ^a   ElAshry, Rasha ^a   Zaki, Maysaa El Sayed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

ARTHROPATHY; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD EXAMINATION; CHILD; CIRCUMCISION; DISEASE SEVERITY; EGYPT; FEMALE; HEMARTHROSIS; HEMATOMA; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; PRESCHOOL CHILD; PREVALENCE; SCREENING TEST;

EID: 79952782215     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2010.025     Document Type: Article

References (17)

1. Blanchette VS, Sparling C, Turner C. Inherited bleeding disorders. Baillieres Clin Haematol 1991; 4:291-332.
2. Lippi G, Franchini M, Guidi GC. Diagnostic approach to inherited bleeding disorders. Clin Chem Lab Med 2007; 45:2-12.
3. Ziv O, Ragni MV. Bleeding manifestations in males with von Willebrand disease. Haemophilia 2004; 10:162-168.
4. Federici AB. Diagnosis of inherited von Willebrand disease: a clinical perspective. Semin Thromb Hemost 2006; 32:555-565.
5. KAR A and Mpotnis. LELE Descriptive epidemiology of haemophiia in Maharashtra india (2001). Haemophilia, 7, 561-567
6. Al Fawaz IM, Gader AMA, Bahakim HM, Al Mohareb F, AlMomen AK, Harakati MS. Hereditary bleeding disorders in Riyadh, Saudi Arabia. AnnSaudi Med 1996; 16:257-261.
7. Al Sabti EA, Hammadi IM. Inherited bleeding disorders in Jordan. Acta Hematol 1979; 61:47-51.
8. EL-Bostany E A, Omerb N, Salama E E, El-Ghoroury E A, Al-Jaouni S K. The spectrum of inherited bleeding disorders in pediatrics.. Blood Coagulation and Fibrinolysis 2008, 19: 8/771-775.
9. Chandy M. Management of haemophilia in developing countries with available resources. Haemophilia 1995; 1 (1): 44±8.
10. Srivastava A, Chuansumrit A, Chandy M, Duraiswamy G, Karagus C. Management of haemophilia in the developing world. Haemophilia 1998; 4 (4): 474±80.
11. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, Dusheiko GM, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 1997; 350:1425-31.
12. 12. Makris M, Preston FE, Triger DR, Underwood JC, Choo QL, Kuo G, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335:1117-9.
13. Mandalaki T Management of haemophilia m Greece Thromb Haemost 1976,35 522-30
14. Yanmtsioüs A, Bossmakou I Louizou C, Panayotopoulou C, Mandalaki T Jaundice and hepatitis B surface antigen and antibody m Greek haemophi hacs Scandl Haematol 1977, 30 11-5
15. LaissonSA Lite expectancy of Swedish Haemophihacs, 1831-1980 BrJ Haematol 1985, 59 593-602
16. Rizza CR, Spooner RJD. Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-1980: report on behalf ofthe directors of haemophilia centres in the United Kingdom. Br Med J 1983; 286: 929-33.
17. Hatzakis A, Hadziyannis S, Maclure M, Louizou C, Yannitsiotis A, Mandalaki T. Concurrent hepatitis B, delta and human immunodeficiency virus infection in hemophiliacs. Thromb Haemost 1987; 58: 791.